Agios Pharmaceuticals (AGIO) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 18, 2026, to be held virtually, with registration required by June 16, 2026.

• Proxy materials are available online, with options to request paper or email copies by June 8, 2026.

Voting matters and shareholder proposals

• Election of three Class I director nominees for three-year terms expiring at the 2029 annual meeting.

• Advisory vote to approve compensation for named executive officers.

• Proposal to amend the 2023 Stock Incentive Plan to increase available shares by 2,000,000.

• Ratification of PricewaterhouseCoopers LLP as independent auditor for fiscal year ending December 31, 2026.

Board of directors and corporate governance

• Board recommends voting for all director nominees and all proposals presented.

• Director nominees include Rahul Ballal, Ph.D., Brian Goff, and Cynthia Smith.